Found 21 matching trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
PHASE2Tourette's Syndrome is a neurological disease characterized by motor and vo...
Ecopipam Treatment of Tourette Syndrome
PHASE1Tourette's Syndrome is a neurological disease characterized by verbal and m...
Location
Johns Hopkins University
Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder
N/AThe goal of this expanded access study is to learn about the long-term effe...
Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
PHASE3The purpose of this research study is to gather scientific information abou...
Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease
PHASE1The purpose of this study is to determine the effects of ecopipam in patien...
Location
University of California at San Diego
Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam
PHASE1Ecopipam hydrochloride (HCl) is an investigational drug being studied for s...
Location
SNBL Clinical Pharmacology Center, Inc.
Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite
PHASE1This is a single center, open-label, fixed sequence, drug-drug interaction ...
Location
Syneos Health Clinical Research Services, LLC.
Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization
PHASE1THOROUGH QT/QTc STUDY TO EVALUATE THE EFFECTS OF ECOPIPAM (EBS-101) ON CARD...
Location
PPD Austin Phase 1 Clinical Research Unit
Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)
PHASE2This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).
PHASE2The primary objective of this study is to evaluate the efficacy and tolerab...